PPB - Services

Complaints, Feedback and Enquiry

Pharmacovigilance Summary Report: 1st October to 31st December 2023 (Q2)

[featured_image]
  • Version
  • Download 312
  • File Size 552.26 KB
  • File Count 1
  • Create Date January 18, 2024
  • Last Updated January 18, 2024

Pharmacovigilance Summary Report: 1st October to 31st December 2023 (Q2)

The Pharmacy and Poisons Board is the National Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya. The Board regulates the Practice of Pharmacy and the manufacture and trade of drugs and poisons. The PPB has 4 directorates of which the Directorate of Product Safety (PDS) is responsible for Pharmacovigilance, Post-Marketing Surveillance, Clinical Trials & Medicines Information activities. PDS shares quarterly pharmacovigilance reports with stakeholders to serve as a feedback mechanism and also encourage all stakeholders to report adverse events. Since the introduction of PV in Kenya, a total of 19,754 individual case safety reports (ICSRs) have been submitted to the global database representing 2.7% of the total ICSRs submitted by African countries.

Attached Files

FileAction
Pharmacovigilance Quarterly Summary for Quarter 2 (1st Oct - 31st Dec).pdfDownload

Author

Tony Kemboi

Leave a comment

Your email address will not be published. Required fields are marked *